According to what has been proposed, CALR mutations could be used as a diagnostic tool in the same way JAK2 alterations have improved accuracy of current diagnosis of essential thrombocythemia and primary myelofibrosis. This evidence concerns the gene JAK2 and essential thrombocythemia.